Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VXA-G1.1-NN boost optimization in healthy adults
NCT04875676Phase 2Completed
- Sponsor
- Vaxart, Inc.
- Start
- Apr 2021
- Primary completion
- Oct 2021
- Modality
- Drug Delivery Systems, Vaccines & Immunotherapeutics, Adenoviral Vectors
- Countries
- 1
01
Overview
A Phase 2 trial of VXA-GI.1.NN in norovirus infection, sponsored by Vaxart, Inc.. Started Apr 2021; status: completed.
02
Drugs
VXA-GI.1.NN
03
Conditions
norovirus infection
Beyond the preview
Go deeper on NCT04875676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04875676.